CARCLO PLC

AGM Information • Sep 2, 2016

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 8363I

Carclo plc

02 September 2016

For immediate release                                                                                         2 September 2016

Carclo plc

Result of AGM Resolutions

Carclo plc announces that all resolutions proposed at the Annual General Meeting yesterday were passed on a show of hands. Resolution 3, set out in the Notice of the AGM, relating to the declaration of a final dividend, had become redundant in the light of the Company's announcement made on 31 August 2016, and was therefore, with the approval of the meeting, not proposed to the shareholders. 

In accordance with Listing Rule 9.6.2, copies of the resolutions passed as special business will be submitted to the UK Listing Authority via the National Storage Mechanism, which can be accessed at www.morningstar.co.uk.

The items of special business approved at the AGM were:

(i)         authority to allot shares pursuant to Section 551 of the Companies Act 2006.

(ii)        Disapplication of pre-emption rights upon the allotment of equity securities for cash pursuant to Section 570 of the Companies Act 2006.

(iii)       authority to make market purchases of shares pursuant to Section 701 of the Companies Act 2006.

(iv)       approval to call general meetings (other than annual general meetings) on 14 clear days' notice.

A half year trading update will be issued during the week commencing 10 October 2016.

- ENDS -

Enquiries:
Carclo plc	01924 268040
Chris Malley, Chief Executive
Robert Brooksbank, Finance Director
Weber Shandwick Financial	020 7067 0700
Nick Oborne

Notes to editors

Carclo plc is a public company whose shares are quoted on the London Stock Exchange.

Carclo's strategy is to develop and expand its key manufacturing assets where there remain significant further opportunities to drive value. To enhance profit margins and support customers the Group has been investing in lower cost regions and new technologies.

Approximately three fifths of Group revenues are derived from the supply of fine tolerance, injection moulded plastic components, mainly for medical products. The balance of revenue is derived mainly from the design and supply of specialised injection moulded LED based lighting systems to the low volume premium automotive industry.

This information is provided by RNS

The company news service from the London Stock Exchange

END

RAGSSAFSEFMSELU